| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
Department of Immunology, National Institute of Animal Health, Tsukuba, Japan.
The KK mouse is considered suitable as a polygenic model for human non-insulin-dependent diabetes mellitus. To identify the quantitative trait loci (QTLs) responsible for hyperglycemia and impaired glucose tolerance in KK mice, linkage analysis using 97 microsatellite markers was carried out in a 192 F2 progeny, comprising 93 mice with the a/a genotype at the agouti locus (chromosome 2) and 99 mice with the Ay/a genotype, produced by a cross between a C57BL/6J female and a KK-Ay (Ay congenic) male. In F2 a/a progenies, we identified a QTL for fasting glucose levels on chromosome 6 (LOD score 6.0) and three loci with suggestive linkage on chromosomes 3, 5 and 14, but could not identify loci accounting for glucose tolerance and plasma insulin levels. In F2 Ay/a progenies, there were no loci with statistically significant linkage, but three suggestive loci were identified: a locus for fasting glucose on chromosome 9, and two loci for glucose tolerance on chromosomes 1 and 8. It would thus appear that. although the fasting glucose level is controlled by QTLs in KK mice, these QTLs may be masked by the strong hyperglycemic influence of the Ay allele. Suggestive loci accounting for glucose tolerance may interact with the Ay allele, since these loci were identified only in F2 Ay/a progeny. This is consistent with the finding that the impaired glucose tolerance in KK mice is moderate and becomes overt when associated with the Ay allele.
This article has been cited by other articles:
|
|
 |
|
  B. G. Han, C.-M. Hao, E. E. Tchekneva, Y.-Y. Wang, C. A. Lee, B. Ebrahim, R. C. Harris, T. S. Kern, D. H. Wasserman, M. D. Breyer, et al. Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E981 - E986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hada, M. Kobayashi, M. Fujiyoshi, A. Ishikawa, M. Kuga, M. Nishimura, S. Ebihara, T. Ohno, and F. Horio Quantitative trait loci for impaired glucose tolerance in nondiabetic SM/J and A/J mice Physiol Genomics, September 17, 2008; 35(1): 65 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schmidt, N. P. Gonzaludo, S. Strunk, S. Dahm, J. Schuchhardt, F. Kleinjung, S. Wuschke, H.-G. Joost, and H. Al-Hasani A meta-analysis of QTL for diabetes-related traits in rodents Physiol Genomics, June 1, 2008; 34(1): 42 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Clee and A. D. Attie The Genetic Landscape of Type 2 Diabetes in Mice Endocr. Rev., February 1, 2007; 28(1): 48 - 83. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Iwai, H.-S. Li, R. Chen, T. Shiuchi, L. Wu, L.-J. Min, J.-M. Li, M. Tsuda, J. Suzuki, Y. Tomono, et al. Calcium Channel Blocker Azelnidipine Reduces Glucose Intolerance in Diabetic Mice via Different Mechanism Than Angiotensin Receptor Blocker Olmesartan J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1081 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Galkina and K. Ley Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy J. Am. Soc. Nephrol., February 1, 2006; 17(2): 368 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ando, H. Yanagihara, Y. Hayashi, Y. Obi, S. Tsuruoka, T. Takamura, S. Kaneko, and A. Fujimura Rhythmic Messenger Ribonucleic Acid Expression of Clock Genes and Adipocytokines in Mouse Visceral Adipose Tissue Endocrinology, December 1, 2005; 146(12): 5631 - 5636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Qi, H. Fujita, J. Jin, L. S. Davis, Y. Wang, A. B. Fogo, and M. D. Breyer Characterization of Susceptibility of Inbred Mouse Strains to Diabetic Nephropathy Diabetes, September 1, 2005; 54(9): 2628 - 2637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Breyer, E. Bottinger, F. C. Brosius III, T. M. Coffman, R. C. Harris, C. W. Heilig, K. Sharma, and for the AMDCC Mouse Models of Diabetic Nephropathy J. Am. Soc. Nephrol., January 1, 2005; 16(1): 27 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shiuchi, M. Iwai, H.-S. Li, L. Wu, L.-J. Min, J.-M. Li, M. Okumura, T.-X. Cui, and M. Horiuchi Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic Mice Hypertension, May 1, 2004; 43(5): 1003 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kobayashi, T. Ohno, A. Tsuji, M. Nishimura, and F. Horio Combinations of Nondiabetic Parental Genomes Elicit Impaired Glucose Tolerance in Mouse SMXA Recombinant Inbred Strains Diabetes, January 1, 2003; 52(1): 180 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wu, D. A. Okar, C. B. Newgard, and A. J. Lange Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E38 - E45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Lin, H. Ortsater, H. Fakhrai-Rad, J. Galli, H. Luthman, and P. Bergsten Phenotyping of Individual Pancreatic Islets Locates Genetic Defects in Stimulus Secretion Coupling to Niddm1i Within the Major Diabetes Locus in GK Rats Diabetes, December 1, 2001; 50(12): 2737 - 2743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shike, S. Hirose, M. Kobayashi, K. Funabiki, T. Shirai, and Y. Tomino Susceptibility and Negative Epistatic Loci Contributing to Type 2 Diabetes and Related Phenotypes in a KK/Ta Mouse Model Diabetes, August 1, 2001; 50(8): 1943 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Brown, J. Zhang, Y. Du, J. Stoll, W. M. Yokoyama, and A. A. Scalzo Localization on a Physical Map of the NKC-Linked Cmv1 Locus Between Ly49b and the Prp Gene Cluster on Mouse Chromosome 6 J. Immunol., August 15, 1999; 163(4): 1991 - 1999. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
